GIP is the main incretin hormone in healthy people, causative of most the incretin effects, but the insulin response after GIP secretion in type 2 diabetes mellitus (T2DM) is strongly reduced
Tirzepatide also outperforms single-agonist medications in head-to-head comparisons, which is why researchers are so interested in how it compares to both semaglutide and newer triple agonists like retatrutide
When you take semaglutide, it binds to GLP-1 receptors in your body, leading to several effects: Appetite Suppression: Semaglutide can help you feel fuller for longer, reducing your overall calorie intake
Its reduced IGFBP affinity makes it a preferred tool for distinguishing receptor-mediated effects from binding-protein-mediated sequestration
Rotating between body sites (thighs, abdomen, upper arms) is clinically safe and actually reduces lipodystrophy risk by distributing injections across larger tissue areas